Competing interests
JP, SBC, JRA
JRA
SDL has received consulting fees from Cornerstones, Eli Lilly, Janssen, Pfizer Inc, and UCB Pharma; and grant support from AbbVie, Arena, Atlantic, Celgene, Gilead Sciences, Janssen, Pfizer Inc, Salix, Shield, Takeda, Tetherex, and UCB Pharma. JRA has received consulting fees from Artugen, Bacainn, Bristol-Myers Squibb, Celgene, Finch Therapeutics, Iterative Scopes, Janssen, Morphic, Pandion, and Pfizer Inc; and grant support from Merck. FS has served as an advisory board member for Pfizer Inc; and has received consulting fees and speaker fees from AbbVie, Amgen, Eurofarma, Ferring Pharmaceuticals, Janssen, Novartis, Sandoz, Takeda, and UCB Pharma. SBC and NL are employees and stockholders of Pfizer Inc. JP is an employee of Syneos Health, which was a paid contractor to Pfizer in connection with the development of this manuscript and related statistical analysis. KBG has received grant support from Celltrion and Pfizer Inc; and personal fees from AbbVie, Arena, Celltrion, Ferring Pharmaceuticals, Galapagos, Gilead Sciences, Immunic, Janssen, Novartis, Pfizer Inc, Roche, Samsung Bioepis, Takeda, and Tillotts.